In 2023, government expenditures on R&D health in Italy stood at an estimated value just above 1.25. From 2024 to 2028, a slight downward trend is forecasted with the value decreasing annually. The year-on-year variation suggests a modest decline, with annual values decreasing by approximately 0.01-0.02 each year. The compound annual growth rate (CAGR) over the five-year period shows an average annual shrinkage, indicative of a gradual reduction in government spending on health R&D.
Future trends to watch include potential policy changes that could either reverse the forecasted decrease or further exacerbate it. Additionally, advancements in healthcare technology and increasing demands for innovation might prompt adjustments in expenditure priorities. Monitoring political and economic factors will be crucial for understanding future trends in R&D health spending.
